Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment

Tamotsu Sagawa, Masahiro Hirakawa, Hiroyuki Nagashima, Koshi Fujikawa

Open source

DOI
10.1111/ajco.70220
Published
2026-10-30
Container
Asia-Pacific Journal of Clinical Oncology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ajco.70220,
  title = {Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment},
  author = {Tamotsu Sagawa and Masahiro Hirakawa and Hiroyuki Nagashima and Koshi Fujikawa},
  year = {2026},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  doi = {10.1111/ajco.70220},
  url = {https://doi.org/10.1111/ajco.70220}
}

RIS

TY  - JOUR
TI  - Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment
AU  - Tamotsu Sagawa
AU  - Masahiro Hirakawa
AU  - Hiroyuki Nagashima
AU  - Koshi Fujikawa
PY  - 2026
JO  - Asia-Pacific Journal of Clinical Oncology
DO  - 10.1111/ajco.70220
UR  - https://doi.org/10.1111/ajco.70220
ER  - 

APA

Sagawa, T., Hirakawa, M., Nagashima, H., & Fujikawa, K. (2026). Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.70220

Source records